Isolation and identification of a sibutramine analogue in a healthy food for weight loss

被引:0
|
作者
Lai, Kuo-Chih
Liu, Yi-Chu
Tseng, Mu-Chang
Lin, Yun-Lian
Lin, Jer-Huei
机构
[1] Bur Food & Drug Anal, Dept Hlth, Taipei 115, Taiwan
[2] Natl Res Inst Chinese Med, Taipei 112, Taiwan
关键词
sibutramine analogue; adulterants; NMR; FAB mass;
D O I
暂无
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
A sibutramine analogue was detected and added illegally in known as the healthy food that can reduce weight. The structure was determined as N-1-[1-(4-chlorophenyl) cyclobutyl]-3-methylbutyl-N-methylamine with the molecular formula C16H24NCI and molecular weight 265 Da. The sample was desalted and extracted with water, further purified by a liquid-liquid partition method. The structure was identified with a series of 1-D and 2-D NMR techniques, IR and FAB mass. Comparing with the structure of sibutramine, a tertiary amine was substituted as a secondary amine. This is one of the active metabolite of sibutramine. Basic on the law, foods with any illegal additive such as synthetic chemical compound shall not be sold, manufactured, imported, processed, used, prepared, stored or transported. Therefore, this sibutramine analogue has been included in the inspection list of illegal adulterants in Taiwan.
引用
收藏
页码:20 / 24
页数:5
相关论文
共 50 条
  • [22] Does prior authorization of sibutramine improve medication compliance or weight loss?
    Risser, JA
    Vash, PD
    Nieto, L
    OBESITY RESEARCH, 2005, 13 (01): : 86 - 92
  • [23] Effects of sibutramine-induced weight loss on patients with metabolic syndrome
    Fujioka, K
    Pirner, M
    Hewkin, A
    Renz, C
    OBESITY RESEARCH, 2003, 11 : A110 - A110
  • [24] Effects of sibutramine on resting metabolic rate and weight loss in overweight women
    Seagle, HM
    Bessesen, DH
    Hill, JO
    OBESITY RESEARCH, 1998, 6 (02): : 115 - 121
  • [25] Additive effects of weight loss and sibutramine in managing hypertensive patients - An analysis of the sibutramine cardiovascular outcomes (SCOUT) trial
    Maggioni, A.
    Caterson, I.
    Coutinho, W.
    Finer, N.
    Van Gaal, L.
    Sharma, A.
    Torp-Pedersen, C.
    James, P.
    JOURNAL OF HYPERTENSION, 2007, 25 : S290 - S290
  • [26] Optimum treatment for hypertension during sibutramine-induced weight loss
    Nature Clinical Practice Cardiovascular Medicine, 2007, 4 (9): : 464 - 464
  • [27] Weight loss from combination therapy with sibutramine and meal replacement.
    Fernstrom, M
    Deaton, R
    Apovian, C
    Aronne, L
    Early, J
    Frank, A
    Greenway, F
    Heber, D
    Kushner, R
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2002, 75 (02): : 375S - 375S
  • [28] Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine
    Hainer, V
    Kunesova, M
    Bellisle, F
    Hill, M
    Braunerova, R
    Wagenknecht, M
    INTERNATIONAL JOURNAL OF OBESITY, 2005, 29 (02) : 208 - 216
  • [29] Reduction in left ventricular mass with weight loss on sibutramine treatment for obesity
    Zannad, F.
    Ziegler, O.
    Gilles, B.
    Grentzinger, A.
    Bruntz, J. F.
    Hammadi, M.
    Boivin, J. M.
    Hanotin, C.
    Drouin, P.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2001, 15 : 123 - 123
  • [30] Long-term weight loss with sibutramine - A randomized controlled trial
    Wirth, A
    Krause, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (11): : 1331 - 1339